CTRI/2020/12/029543尚未招募未知
Role of Flecainide in assessment of atrioventricular conduction in symptomatic bifascicular block
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •study population will consist of symptomatic patient admitted with bifasicular block for permanent pacing
排除标准
- •patient with established indication for pacing.
- •1- Third degree AV block( CHB)
- •2- Mobitz II
- •3-Advanced AVB
- •4-LVEF <35%
研究者
相似试验
尚未招募
4 期
Effects of vernakalant and flecainide on atrial contractility in patients with atrial fibrillatioatrial fibrillationNL-OMON37797Medisch Universitair Ziekenhuis Maastricht50
进行中（未招募）
不适用
Effects of vernakalant and flecainide on atrial contractility in patients with AFPatients with paroxysmal or persistent atrial fibrillation (AF) reporting at the first heart aid.EUCTR2012-001898-90-NLMaastricht University Medical Center
招募中
不适用
In-vivo Bioequivalence Test of Flecainide acetate tablets with brand drug (TAMBOCOR® 100 mg FC Tab, MEDA Pharmaceuticals LLC, USA)IRCT20200105046010N48Arena Hayat Danesh Pharmaceutical Company24
Unknown
4 期
Vernakalant Versus Flecainide: Atrial ContractilityAtrial FibrillationNCT01646281Maastricht University Medical Center70
进行中（未招募）
不适用
REPEATED I.V. BOLUSES FLECAINIDE FOR ACUTE ATRIAL FIBRILLATION TERMINATION A SINGLE BLIND RANDOMIZED REGIMEN CONTROLLED TRIAL. - NDATRIAL FIBRILLATIONEUCTR2007-000204-33-ITAZIENDA OSPEDALIERA OSPEDALE DI CIRCOLO A.O. DI RILIEVO REGIONALE